HomeANTX • NASDAQ
add
AN2 Therapeutics Inc
Previous close
$1.10
Day range
$1.08 - $1.12
Year range
$0.87 - $3.07
Market cap
33.19M USD
Avg Volume
325.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.54M | -36.94% |
Net income | -10.65M | 35.92% |
Net profit margin | — | — |
Earnings per share | -0.35 | 37.50% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 67.06M | -41.28% |
Total assets | 81.34M | -32.92% |
Total liabilities | 8.01M | -24.84% |
Total equity | 73.33M | — |
Shares outstanding | 30.18M | — |
Price to book | 0.45 | — |
Return on assets | -33.26% | — |
Return on capital | -37.17% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.65M | 35.92% |
Cash from operations | -10.62M | 39.61% |
Cash from investing | 9.19M | -65.03% |
Cash from financing | 65.00K | -81.38% |
Net change in cash | -1.37M | -115.10% |
Free cash flow | -7.24M | 36.02% |
About
Founded
2017
Headquarters
Website
Employees
22
